Pfizer - Biosimilars Research and Education in Solid Tumors

Sponsor Deadline: 

Oct 16, 2019


Pfizer Global Medical

UI Contact: 

Pfizer:  Biosimilars Research in Solid Tumors
Deadline October 15, 2019
Clinical Area: Oncology - Biosimilars: trastuzumab-qyyp or bevacizumab-bvzr

Pfizer: Biosimilars Medical Education in Solid Tumors
deadline October 16, 2019

The goal of this RFP is to support safe and effective use of biosimilar drugs in the treatment of solid tumors, in particular colorectal cancer and HER2+ breast cancer.